Biopharmaceutical firms engaged in developing weight-loss drugs were rewarded rather significantly in 2024. Advertisement
Wajeeh Khan is a financial reporter for invezz, with his work also appearing in CoinJournal and Knowledia. He covers a wide range of topics in the financial sector, including investigations into companies, CEO statements, stock market trends, and mergers and acquisitions. Wajeeh provides insightful analysis and reporting on the latest developments in the world of finance.